Lifestyle Intervention Yields Sustained Improvements in Type 2 Diabetes

“Longer follow-up will allow us to determine whether the differences between groups in CVD risk factors can be maintained and whether the [intensive intervention] has positive effects on cardiovascular morbidity and mortality,” Dr. Wing and her associates said.

Disclosures: The LookAHEAD study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Nursing Research; National Center on Minority Health and Health Disparities; Office of Research on Women’s Health; Centers for Disease Control and Prevention; U.S. Department of Veterans Affairs; Indian Health Service; and general clinical research centers at Johns Hopkins Medical Institutions, Massachusetts General Hospital, Massachusetts Institute of Technology, Colorado Health Sciences Center, University of Tennessee at Memphis, and the University of Pittsburgh. In addition, FedEx Corp., Health Management Resources, LifeScan Inc., OPTIFAST, Hoffmann-La Roche, Abbott Nutrition, and Slim-Fast have committed to make major contributions to the ongoing trial. Dr. Wing’s associates reported financial ties to BodyMedia Inc., University of Pittsburgh Medical Center Health Plan, Proctor & Gamble, and Free & Clear.